L-DOPA modulates striatal dopaminergic function in vivo: Evidence from PET investigations in nonhuman primates

Synapse

Volumn 25, Issue 1, 1997, Pages 56-61

  Tedroff, J ^a,b   Torstenson, R ^a   Hartvig, P ^a   Lindner, K J ^a   Watanabe, Y ^a   Bjurling, P ^a   Westerberg, G ^a   Langstrom B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

dopamine; L 11C DOPA; L DOPA; monkey; PET

Indexed keywords

BIOPTERIN; LEVODOPA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; FEMALE; MENTAL DISEASE; NERVE DEGENERATION; NERVE ENDING; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; CORPUS STRIATUM; DOPAMINE; FEMALE; LEVODOPA; MACACA MULATTA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031023088     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199701)25:1<56::AID-SYN7>3.0.CO;2-E     Document Type: Article

References (35)

1. Agid, Y. (1991) Parkinson's disease: Pathophysiology. Lancet, 337:1321-1324.
2. Andersson, J.L.R. (1995) A rapid and accurate method to realign PET scans utilizing image edge information. J. Nucl. Med., 36:657-669.
3. Bendriem, B., Dewey, S.L., Schlyer, D.J. Wolf, A.P., and Volkow, N.D. (1991) Quantitation of the human basal ganglia with positron emission tomography: A phantom study of the effect of contrast and axial positioning. IEEE Trans. Med. Imaging, 10:216-222.
4. Bergström, M., Hartvig, P., Nava, C., de Paolis, C., and Långstöm, B. (1995) Effects of cabergoline on striatal dopamine receptor binding and dopamine synthesis - in vivo study in monkey with positron emission tomography. The Meeting of European Neuroscience, Amsterdam, the Netherlands, p. 24 (abstract).
5. 11C-labelled L-tyrosine and L-DOPA. Acta Chem. Scand., 44:183-188.
6. Bowsher, R.R., and Henry, D.P. (1986) Aromatic L-amino acid decarboxylase: Biochemistry and functional significance. In: Neuromethods, Series 1: Neurochemistry, Neurotransmitter Enzymes. A.A. Boulton, G.B. Baker, and P.H. Yu, eds. Humana Press, Clifton, NJ, pp. 33-77.
7. Carson, R.E., Huang, S.-C., and Green, M.V. (1986) Weighted integration method for local cerebral blood flow measurements with positron emission tomography. J. Cereb. Blood Flow Metab., 6:245-258.
8. Davis, K.L., Kahn, R.S., Ko, G., and Davidson, M. (1991) Dopamine in schizophrenia: A review and reconceptualization. An. J. Psychiatry, 148:1474-1486.
9. Hadjiconstantinou, M., Wemlinger, T.A., Sylvia, C.P., Hubble, J.P., and Neff, N.H. (1993) Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J. Neurochem., 60:2175-2181.
10. 11C]-L-DOPA in humans studied by positron emission tomography. J. Neural Transm. Gen. Sect., 87:15-22.
11. 11C]-L-DOPA following COMT inhibition. A study in vivo using PET. J. Neural Transm. Gen. Sect., 87:15-22.
12. Hartvig, P., Tedroff, J., Lindneŕ, K.-J., Bjurling, P., Chang, C.W., Tsukada, H., Watanabe, Y., and Långström B. (1993) Positron emission tomographic studies on aromatic amino acid decarboxylase affinity for 11C-labelled L-DOPA and 5-hydroxy-tryptophan in the monkey brain. J. Neural Transm., 94:127-135.
13. Holte, S., Eriksson, L., and Dahlbom, M. (1989) A preliminary evaluation of Scanditronix PC 2048-15B scanner. Eur. J. Nucl. Med., 15:719-721.
14. Kaufman, S. (1958) A new cofactor required for the enzymatic conversion of phenylalanine to tyrosine. J. Biol. Chem., 234:931-939.
15. Komori, K., Uesaka, S., Yamaoka, H., Fujita, K., Yamaoka, K., Naitoh, H., Kuroda, M., Karasawa, N., Kasahara, Y., and Nagatsu, I. (1993) Identification of L-DOPA immunoreactivity in some neurons in the human mesencephalic region: A novel DOPA neuron group? Neurosci. Lett., 157:13-16.
16. Koob, G.F., and Bloom, F.E. (1988) Cellular and molecular mechanisms of drug dependence. Science, 242:715-723.
17. Kops, R.E., Herzog, H., Schmid, A., Holte, S., and Feinendegen, L. (1990) Performance characteristics of an eight ring whole body PET scanner. J. Comput. Assist. Tomogr., 14:437-445.
18. Koshimura, K., Miwa, S., and Watanabe, Y. (1994) Dopamine-releasing action of 6R-L-erythro-tetrahydrobiopterin: Analysis of its action site using sepiapterin. J. Neurochem., 63:649-654.
19. 11C]DOPA and its metabolites for the validation of positron emission tomography studies. J. Pharm. Biomed. Anal., 13:361-367.
20. Lovenberg, W., Jequier, E., and Sjoerdsma, A. (1967) Tryptophan hydroxylation: Measurement in pineal gland, brainstem, and carcinoid tumor. Science, 155:217-219.
21. Menza, M.A., Golbe, L.I., Cody, R.A., and Forman, N.E. (1993) Dopamine related personality traits in Parkinson's disease. Neurology, 43:505-508.
22. Misu, Y., and Goshima, Y. (1993) Is L-DOPA an endogenous neurotransmitter? Trends Pharmacol. Sci. 14:119-123.
23. Nagatsu, T., Levitt, M., and Undenfriend, S. (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem., 239:2910-2917.
24. Ritz, M.C., Lamb, R.J., Goldeberg, S.R., and Kuhar, M.J. (1987) Cocaine receptors on dopamine transporters are related to the self administration of cocaine. Science, 237:1219-1223.
25. Strömbom, U. (1976) Catecholamine receptor agonists: Effects on motor activity and rate of tyrosine hydroxylationin mouse brain. Nanyn Schmiedelbergs Arch. Pharmacol., 292:167-176.
26. Tani, Y., Ishihara, T., Kanai, T., Ohno, T., Andersson, J., Lilja, A., Antoni, G., Fasth, K.J., Bjurling, P., Westerber, G.,Hartvig, P., Onoe, H., Watanabe, Y., and Långström, B. (in press) Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptor as evaluated by positron emission tomography in the rhesus monkey. J. Neural. Transm. Gen. Sect.
27. Tedroff, J., Hartvig, P., Bjurling, P., Andersson, Y., Antoni, G., and Långström, B. (1991) Central action of benserazide after COMT inhibition demonstrated in vivo by PET. J. Neural Transm. Gen. Sect., 85:11-17.
28. 11C]-L-3,4-dihydroxyphenyl alanine (DOPA) in the primate by positron emission tomography. Acta Neurol. Scand., 85:166-173.
29. Tedroff, J., Aquilonius, S.-M., Hartvig, P., and Långström, B. (1995) Functional positron emission tomographic studies of striatal dopaminergic activity. Changes induced by drugs and nigrostriatal degeneration. Adv. Neurol., 69:443-448.
30. 11C]DOPA turnover in the rat striatum with infusion of L-tyrosine. J. Neural Transm. Gen. Sect., 95:1-5.
31. Tsukada, H., Lindner, K.J., Hartvig, P., and Långström, B. (1994b) Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the extracellular levels of dopamine and serotonin in the rat striatum: A microdialysis study with tyrosine and tryptophan infusion. Brain Res., 635:59-67.
32. 11C]raclopride in the human brain. Synapse, 16:255-262.
33. 11C-dopamine turnover in vivo by peripheral administration of 6R-tetrahydrobiopterin in monkey striatum. In: Pteridine and Related Biogenic Amines in Neuropsychiatry, Pediatrics and Immunology. N. Bleu, H-Ch. Curtius, R.A. Levine, and R.G.H. Cotton, eds. Lakeshore Publishing Company, Grosse Pointe, WI, pp. 353-362.
34. Wise, R.A. (1988) Catecholamine theories of reward: A critical review. Brain Res., 152:215-217.
35. Zhu, M.Y., Juorio, A.V., Paterson, A., and Boulton, A.A. (1993) Regulation of striatal aromatic L-amino acid decarboxylase: Effects of blockade or activation of dopamine receptors. Eur. J. Pharmacol., 238:157-164.